JPMORGAN CHASE & CO

Position in LENZ — LENZ Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in LENZ

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$99,578

-$51,862 QoQ

Shares Held

10,883

+15.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 25.507672516769276.ToString("F0")% Shared 0.ToString("F0")% None 74.49232748323072.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. LENZ ranks #233 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$99,578	10,883	+15.0%	Shares	Defined	2026-05-13
2025-12-31	$151,440	9,465	-15.7%	Shares	Defined	2026-02-11
2025-09-30	$522,719	11,222	+8.3%	Shares	Defined	2025-11-26
2025-06-30	$303,679	10,361	+28.7%	Shares	Defined	2025-08-12
2025-03-31	$206,989	8,051	-3.5%	Shares	Defined	2025-05-12
2024-12-31	$240,831	8,342	+46.4%	Shares	Defined	2025-02-12
2024-09-30	$135,293	5,699	+5.1%	Shares	Defined	2024-12-26
2024-06-30	$93,711	5,420	+222.2%	Shares	Defined	2024-12-26
2024-03-31	$37,558	1,682	—	Shares	Defined	2024-12-26
No filing history on record for this holder in this stock.